Cationic solid lipid nanoparticles with cholesterol-mediated surface layer for transporting saquinavir to the brain

Biotechnology Progress

Volumn 30, Issue 1, 2014, Pages 198-206

  Kuo, Yung Chih ^a   Wang, Cheng Chin ^a  

^a NATIONAL CHUNG CHENG UNIVERSITY   (Taiwan)

Author keywords

Astrocyte; Blood brain barrier; Cationic solid lipid nanoparticle; Cholesterol; Endothelial cell; Saquinavir

Indexed keywords

ASTROCYTE; BLOOD-BRAIN BARRIER; CATIONIC SOLID LIPID NANOPARTICLES; DRUG DELIVERY SYSTEM; FLUORESCENT STAINING; HUMAN BRAIN-MICROVASCULAR ENDOTHELIAL CELLS; MORPHOLOGICAL IMAGES; SAQUINAVIR;

BLOOD; DRUG DELIVERY; ENDOTHELIAL CELLS; NANOPARTICLES;

CHOLESTEROL;

THEOBROMA; THEOBROMA CACAO;

CATION; CATIONIC SOLID LIPID NANOPARTICLE; CHOLESTEROL; DRUG CARRIER; FLUORESCENT DYE; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR; LIPID; NANOPARTICLE; SAQUINAVIR;

ARTICLE; ASTROCYTE; BIOLOGICAL MODEL; BLOOD BRAIN BARRIER; CELL MEMBRANE PERMEABILITY; CHEMISTRY; ENDOTHELIUM CELL; HUMAN; METABOLISM; PARTICLE SIZE;

ASTROCYTE; BLOOD-BRAIN BARRIER; CATIONIC SOLID LIPID NANOPARTICLE; CHOLESTEROL; ENDOTHELIAL CELL; SAQUINAVIR;

ASTROCYTES; BLOOD-BRAIN BARRIER; CATIONS; CELL MEMBRANE PERMEABILITY; CHOLESTEROL; DRUG CARRIERS; ENDOTHELIAL CELLS; FLUORESCENT DYES; HIV PROTEASE INHIBITORS; HUMANS; LIPIDS; MODELS, BIOLOGICAL; NANOPARTICLES; PARTICLE SIZE; SAQUINAVIR;

EID: 84893746019     PISSN: 87567938     EISSN: 15206033     Source Type: Journal    
DOI: 10.1002/btpr.1834     Document Type: Article

References (48)

1. Gan CW, Feng SS. Transferrin-conjugated nanoparticles of poly(lactide)-d-α-tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood-brain barrier. Biomaterials. 2010;31:7748-7757.
2. Agarwal A, Agrawal H, Tiwari S, Jain S, Agrawal GP. Cationic ligand appended nanoconstructs: a prospective strategy for brain targeting. Int J Pharm. 2011;421:189-201.
3. Venishetty VK, Samala R, Komuravelli R, Kuncha M, Sistla R, Diwan PV. β-hydroxybutyric acid grafted solid lipid nanoparticles: a novel strategy to improve drug delivery to brain. Nanomed-Nanotechnol Biol Med. 2013;9:388-397.
4. Cardarelli F, Pozzi D, Bifone A, Marchini C, Caracciolo G. Cholesterol-dependent macropinocytosis and endosomal escape control the transfection efficiency of lipoplexes in CHO living cells. Mol Pharm. 2012;9:334-340.
5. Kuo YC, Chen HH. Effect of electromagnetic field on endocytosis of cationic solid lipid nanoparticles by human brain-microvascular endothelial cells. J Drug Target. 2010;18:447-456.
6. Kuo YC, Chen HH. Entrapment and release of saquinavir using novel cationic solid lipid nanoparticles. Int J Pharm. 2009;365:206-213.
7. Osaki F, Kanamori T, Sando S, Sera T, Aoyama Y. A quantum dot conjugated sugar ball and its cellular uptake. On the size effects of endocytosis in the subviral region. J Am Chem Soc. 2004;126:6520-6521.
8. Chithrani BD, Ghazani AA, Chan WCW. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett. 2006;6:662-668.
9. Chithrani BD, Chan WCW. Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. Nano Lett. 2007;7:1542-1550.
10. Xiao K, Li Y, Luo J, Lee JS, Xiao W, Gonik AM, Agarwal RG, Lam KS. The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles. Biomaterials. 2011;32:3435-3446.
11. Kuo YC, Lin PI, Wang CC. Targeting nevirapine delivery across human brain microvesscular endothelial cells using transferrin-grafted poly(lactide-co-glycolide) nanoparticles. Nanomedicine. 2011;6:1011-1026.
12. Chung TH, Wu SH, Yao M, Lu CW, Lin YS, Hung Y, Mou CY, Chen YC, Huang DM. The effect of surface charge on the uptake and biological function of mesoporous silica nanoparticles in 3T3-L1 cells and human mesenchymal stem cells. Biomaterials. 2007;28:2959-2966.
13. Yue ZG, Wei W, Lv PP, Yue H, Wang LY, Su ZG, Ma GH. Surface charge affects cellular uptake and intracellular trafficking of chitosan-based nanoparticles. Biomacromolecules. 2011;12:2440-2446.
14. Rejman J, Oberle V, Zuhorn IS, Hoekstra D. Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem J. 2004;377:159-169.
15. Vallhov H, Gabrielsson S, Stromme M, Scheynius A, Garcia-Bennett AE. Mesoporous silica particles induce size dependent effects on human dendritic cells. Nano Lett. 2007;12:3576-3582.
16. Ricardo-Dukelow M, Kadiu-Kieken I, Rozek W, Schlautman J, Persidsky Y, Ciborowski P, Kanmogne GD, Gendelman HE. HIV-1 infected monocyte-derived macrophages affect the human brain microvascular endothelial cell proteome: new insights into blood-brain barrier dysfunction for HIV-1-associated dementia. J Neuroimmunol. 2007;185:37-46.
17. Kuo YC, Chung CY. Transport of zidovudine- and lamivudine-loaded polybutylcyanoacrvlate and methylmethacrylate-sulfopropylmethacrylate nanoparticles across the in vitro blood-brain barrier: characteristics of the drug-delivery system. J Chin Inst Chem Engrs. 2005;36:627-638.
18. Tabbatt K, Sameti M, Olbrich C, Muller RH, Lehr CM. Effect of cationic lipid and matrix lipid composition on solid lipid nanoparticle-mediated gene transfer. Eur J Pharm Biopharm. 2004;57:155-162.
19. Kim HR, Kim IK, Bae KH, Lee SH, Lee Y, Park TG. Cationic solid lipid nanoparticles reconstituted from low density lipoprotein components for delivery of siRNA. Mol Pharmacol. 2008;5:622-631.
20. del Pozo-Rodriguez A, Delgado D, Solinis MA, Gascon AR, Pedraz JL. Solid lipid nanoparticles: formulation factors affecting cell transfection capacity. Int J Pharm. 2007;339:261-268.
21. Kuo YC, Yu HW. Transport of saquinavir across human brain-microvascular endothelial cells by poly(lactide-co-glycolide) nanoparticles with surface poly-(γ-glutamic acid). Int J Pharm. 2011;416:365-375.
22. Kuo YC, Lin SC. Effect of glutamate on the electrical properties of cationic solid lipid nanoparticles containing stearylamine and dioctadecyldimethyl ammonium bromide. J Phys Chem B. 2008;112:4454-4460.
23. Kuo YC, Wang CC. Cationic solid lipid nanoparticles with primary and quaternary amines for release of saquinavir and biocompatibility with endothelia. Colloid Surf B. 2013;101:101-105.
24. Asasutjarit R, Lorenzen SI, Sirivichayakul S, Ruxrungtham K, Ruktanonchai U, Ritthidej GC. Effect of solid lipid nanoparticles formulation compositions on their size, zeta potential and potential for in vitro pHIS-HIV-hugag transfection. Pharm Res. 2007;24:1098-1107.
25. Ramana LN, Sethuraman S, Ranga U, Krishnan UM. Development of a liposomal nanodelivery system for nevirapine. J Biomed Sci. 2010;17:57-66.
26. 4 nanoparticles for camptothecin loading and release. Acta Biomater. 2009;5:1489-1498.
27. Xu L, Anchordoquy TJ. Cholesterol domains in cationic lipid/DNA complexes improve transfection. Biochim Biophys Acta. 2008;1778:2177-2181.
28. Yan ECY, Eisenthal KB. Effect of cholesterol on molecular transport of organic cations across liposome bilayers probed by second harmonic generation. Biophys J. 2000;79:898-903.
29. Schwarz C, Mehnert W. Solid lipid nanoparticles (SLN) for controlled drug delivery II. Drug incorporation and physicochemical characterization. J Microencapsul. 1999;2:205-213.
30. Sperling RA, Parak WJ. Surface modification, function and bioconjugation of colloidal inorganic nanoparticles. Phil Trans R Soc A Math Phys Eng Sci. 2013;368:1333-1383.
31. Kuo YC, Wang CC. Surface molecular composition and electrical property of cationic solid lipid nanoparticles with assembled lipid layer mediated by noncovalent interactions. J Phys Chem C. 2012;116:16999-17007.
32. Gaillard PJ, de Boer AG. Relationship between permeability status of the blood-brain barrier and in vitro permeability coefficient of a drug. Eur J Pharm Sci. 2000;12:95-102.
33. Kuo YC, Su FL. Transport of stavudine, delavirdine, and saquinavir across the blood-brain barrier by polybutylcyanoacrylate, methylmethacrylate-sulfopropylmethacrylate, and solid lipid nanoparticles. Int J Pharm. 2007;340:143-152.
34. Flecher NF, Brayden DJ, Brankin B, Worrall S, Callanan JJ. Growth and characterization of a cell culture model of the feline blood-brain barrier. Vet Immunol Immunopathol. 2006;109:233-244.
35. Kuo YC, Kuo CY. Electromagnetic interference in the permeability of saquinavir across the blood-brain barrier using nanoparticulate carriers. Int J Pharm. 2008;351:271-281.
36. Parikh T, Bommana MM, Squillante E III. Efficacy of surface charge in targeting pegylated nanoparticles of sulpiride to the brain. Eur J Pharm Biopharm. 2010;74:442-450.
37. Brophy KM, Scarlett-Ferguson H, Webber KS. Clinical drug therapy for canadian practice, 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2010.
38. Kuo YC, Yu HW. Expression of ornithine decarboxylase during the transport of saquinavir across the blood-brain barrier using composite polymeric nanocarriers under an electromagnetic field. Colloid Surf B. 2011;88:627-634.
39. Maity AR, Jana NR. Chitosan-cholesterol-based cellular delivery of anionic nanoparticles. J Phys Chem C. 2011;115:137-144.
40. Gosselet F, Candela P, Sevin E, Berezowski V, Cecchelli R, Fenart L. Transcriptional profiles of receptors and transporters involved in brain cholesterol homeostasis at the blood-brain barrier: use of an in vitro model. Brain Res. 2009;1249:34-42.
41. Li G, Simon MJ, Cancel LM, Shi ZD, Ji X, Tarbell JM, Morrison III B, Fu BM. Permeability of endothelial and astrocyte cocultures: in vitro blood-brain barrier models for drug delivery studies. Ann Biomed Eng. 2010;38:2499-2511.
42. Wuest DM, Wing AM, Lee KH. Membrane configuration optimization for a murine in vitro blood-brain barrier model. J Neurosci Methods. 2013;212:211-221.
43. Kuo YC, Lu CH. Effect of human astrocytes on the characteristics of human brain-microvascular endothelial cells in the blood-brain barrier. Colloid Surf B. 2011;86:225-231.
44. Blasi P, Giovagnoli S, Schoubben A, Ricci M, Rossi C. Solid lipid nanoparticles for targeted brain drug delivery. Adv Drug Deliv Rev. 2007;59:454-477.
45. Olivier JC. Drug transport to brain with targeted nanoparticles. NeuroRx. 2005;2:108-119.
46. Andreozzi E, Seo JW, Ferrara K, Louie A. Novel method to label solid lipid nanoparticles with 64Cu for positron emission tomography imaging. Bioconjug Chem. 2011;22:808-818.
47. Tian XH, Lin XN, Wei F, Feng W, Huang ZC, Wang P, Ren L, Diao Y. Enhanced brain targeting of temozolomide in polysorbate-80 coated polybutylcyanoacrylate nanoparticles. Int J Nanomed. 2011;6:445-452.
48. Harach HR, Jasani B, Williams ED. Factor VIII as a marker of endothelial cells in follicular carcinoma of the thyroid. J Clin Pathol. 1983;36:1050-1504.